Marksans Pharma Acquires Netherlands-Based QliniQ B.V. to Strengthen Europe Business
Marksans Pharma is set to acquire Netherlands-based QliniQ BV, a strategic move that expands its footprint in regulated European markets and strengthens its forward-integration strategy through direct market-access capabilities across the European Union (EU).
European Pharmaceutical Market | 01/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy